Side-by-side financials for ABVC and LLY. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ABVC | LLY |
|---|---|---|
| Market cap | - | $1.070 T |
| US-listed rank | - | #10 |
| Revenue (latest FY) | $296.00K | $65.18B |
| Net income (latest FY) | -$7.91M | $20.64B |
| Net margin | -2671.8% | 31.7% |
| P/E (trailing FY) | - | 51.8 |
| SEC filings | 780 | 989 |
In their latest fiscal years, ABVC BIOPHARMA, INC. reported $296.00K in revenue while ELI LILLY & Co reported $65.18B.
Full pages: ABVC BIOPHARMA, INC. and ELI LILLY & Co, or browse the full rankings.